Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04936243 · ClinicalTrials.gov registry record · NA
TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04936243 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 30 participants.
The verdict
NCT04936243, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This research study is comparing telemedicine and face-to-face visits to understand patients' experiences with telemedicine versus face to face visits and to understand when it is and is not appropriate to conduct visits remotely
Interventions
- BEHAVIORAL FOLLOW UP VISIT-TELEMEDICINE
- BEHAVIORAL FOLLOW UP VISIT-FACE TO FACE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2022-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04936243
The ClinicalTrials.gov registry entry for NCT04936243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FOLLOW UP VISIT-TELEMEDICINE is the first listed.
NCT04936243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04936243 about?
NCT04936243 is a clinical study titled "TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)". This research study is comparing telemedicine and face-to-face visits to understand patients' experiences with telemedicine versus face to face visits and to understand when it is and is not appropriate to conduct visits remotely
What is the current status of trial NCT04936243?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-08-01. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT04936243?
The interventions under investigation include: FOLLOW UP VISIT-TELEMEDICINE (BEHAVIORAL), FOLLOW UP VISIT-FACE TO FACE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04936243?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.